ClinicalTrials.gg
Drug

Elebsiran clinical trials

Also written VIR-2218.

studies test it
12
open now
0
in phase 3
2
first study started
2018

How each study uses elebsiran is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Elebsiran
7

Development codes

VIR-2218
10

Studies by the year they started

12 studies that test it; most in 2025 (4)

Studies that test elebsiran, by start year
YearStudies
20181
20202
20211
20222
20232
20254

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
7
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 1

Vir Biotechnology, Inc. (8) · Brii Biosciences Limited (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Virion Therapeutics (1)

Often tested with

Tested in the same studies.

Tobevibart (6) · VRON-0200 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test elebsiran, phase 3 first.

Studies

Open first, then newest update. How each study uses elebsiran is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Given beside what is tested · 5 — elebsiran is usual care or a partner of the new treatment

Codes

What other systems call elebsiran · ClinicalTrials.gg INT018332

  • UNII (FDA) W982Y6N4X7ELEBSIRANOne source FDA
  • NCI Thesaurus C190492ElebsiranOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.